ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CIR Circassia Group Plc

34.00
0.00 (0.00%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Circassia Group Plc LSE:CIR London Ordinary Share GB00BJVD3B28 ORD 0.08P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 34.00 33.10 34.90 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Circassia Share Discussion Threads

Showing 1876 to 1894 of 3200 messages
Chat Pages: Latest  80  79  78  77  76  75  74  73  72  71  70  69  Older
DateSubjectAuthorDiscuss
03/1/2020
09:59
Adams Increases Stake In Circassia Pharmaceuticals

Fri, 3rd Jan 2020 09:50
Alliance News

(Alliance News) - Adams PLC on Friday said it has raised its holding in Circassia Pharmaceuticals Ltd.

Adams, which invests in AIM-listed companies, bought 2.4 million shares on Thursday at an average price of 19.0 pence per share for a total investment of GBP456,229. It brings its holdings in Circassia to 3.1 million shares, an 0.8% stake.

Circassia shares were up 1.4% at 19.70p on Friday morning in London.

The follow-on investment comes after Circassia early in December forecast revenue for 2019 to be between GBP60 million to GBP65 million compared to the GBP48.3 million in 2018.

Following the purchase investment, Adams has a cash balance of around GBP1 million, it said.

Shares in Adams were trading flat at 5.00p each on Friday morning in London.

pro_s2009
03/1/2020
08:12
Thats what makes me think the trading update is within the next couple of weeks. Once people outside of the insiders get a sniff of the figures, and if they are good, then they start buying up as much as they can.
pro_s2009
03/1/2020
00:36
Well, it looks like the overhang at 19p is cleared. hopefully the trading update comes next week or the week after and its a strong one.

If sales are strong, as hes been suggested, then the trading update should spark some serious buying.

pro_s2009
02/1/2020
16:18
Off we go again more institutional buying,nice to see a bit of blue.
100egs
02/1/2020
15:41
make that another 5.5 m
timmy11
02/1/2020
15:40
someone bought 5 and half million shares
timmy11
02/1/2020
15:40
Moving up after those big trades went through
pro_s2009
31/12/2019
10:32
Could be, its one of my selections for 2020. Happy really we enter 2020 at 19p levels, allows for plenty of upside running during the next year.

Expecting a January trading update, so that should hopefully start things rolling in terms of share price appreciation.

pro_s2009
31/12/2019
10:25
Reckon this may well be a new year tip..just look at the broker notes here.
pre
29/12/2019
10:49
Don't forget to get your top 5 picks into the annual UK Stock Challenge for 2020.

Just click on the Entry tab.



.

pro_s2009
27/12/2019
11:50
What were last week's tips costax ?
arab3
27/12/2019
11:24
Idp looks ready for a rally
costax1654x
24/12/2019
08:55
Circassia Pharmaceuticals refutes claims over PPHN product

Circassia acquired exclusive commercialisation rights to LungFit PH in the United States and China
Circassia Pharmaceuticals PLC - Circassia Pharmaceuticals receives termination notice for licencing agreement
One in 500 newborns suffers from the breathing condition

Circassia Pharmaceuticals PLC (LON:CIR) has rejected claims by a licensing partner that it materially breached terms of their agreement over a product for babies with breathing difficulties.

The AIM-listed company has received a notice from BeyondAir, previously known as AIT Therapeutics, to terminate the agreement.

In January, Circassia acquired exclusive commercialisation rights to BeyondAir's LungFit PH product, initially called AirNOvent, in the United States and China.
READ: Circassia completes managerial changes as Johnson becomes executive chairman

LungFit PH is a treatment for persistent pulmonary hypertension (PPHN) in newborns.

PPHN occurs when the pressure in the blood vessels of a baby’s lungs remains high after birth, which can restrict the amount of oxygen flowing around the body.

It is thought to occur in around one in 500 births.

Circassia has refuted the claim of a material breach of the agreement.

“The company will enforce its rights under the agreement and defend its position vigorously,” it added in a statement.

House broker Peel Hunt estimated that "even in a worst-case scenario" removing BeyondAir's contribution from its sales forecasts without any cost offset, "Circassia still turns EBITDA positive in 2020, and maintains a positive cash balance across our forecast period".

........

pro_s2009
24/12/2019
08:27
That's the problem with advfn, they switch off at end of trading day.
I always check with LSE, it's laggy but that trade was reported 15.11.20

minja19
24/12/2019
08:22
Yes, definite accumulation going on.
pro_s2009
23/12/2019
15:25
Buying continues, lets hope the next news is a resolution of the dispute with BeyondAir.

Although the dispute does not effect the immediate short term, as sales were not due to come in until late 2020, it would of course be a boost to the medium term if this was resolved and the potential sales revenue for 2021 reinstated.

pro_s2009
23/12/2019
10:56
Picked up a few more for myself, as I am expecting the next RNS to announce settlement in CIR's favour.
minja19
23/12/2019
09:56
Decent buying today, long may it continue
pro_s2009
23/12/2019
09:32
B B B
Busy Bots Buying, all morning

minja19
Chat Pages: Latest  80  79  78  77  76  75  74  73  72  71  70  69  Older

Your Recent History

Delayed Upgrade Clock